Evidence map›Paper›PMID 25834460›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial.

Akifumi Nagatomo, Norihisa Nishida, Ikuo Fukuhara, Akira Noro, Yoshimichi Kozai, Hisao Sato, Yoichi Matsuura

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Health Functions of Egg Protein.Foods (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Obesity subtypes, related biomarkers & heterogeneity.The Indian journal of medical research · 2020
    Review
  9. Therapeutic Applications of Rose Hips from Different Rosa Species.International journal of molecular sciences · 2017
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Akifumi NagatomoResearch and Development Division, Morishita Jintan Co, Ltd, Osaka, Japan.
Norihisa NishidaResearch and Development Division, Morishita Jintan Co, Ltd, Osaka, Japan.
Ikuo FukuharaFukuhara Clinic, Hokkaido, Japan.
Akira NoroNew Drug Research Center, Inc., Hokkaido, Japan.
Yoshimichi KozaiNew Drug Research Center, Inc., Hokkaido, Japan.
Hisao SatoNew Drug Research Center, Inc., Hokkaido, Japan.
Yoichi MatsuuraResearch and Development Division, Morishita Jintan Co, Ltd, Osaka, Japan.
Morishita Jintan (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity has become a great problem all over the world. We repeatedly screened to find an effective food to treat obesity and discovered that rosehip extract shows potent anti-obesity effects. Investigations in mice have demonstrated that rosehip extract inhibits body weight gain and decreases visceral fat. Thus, the present study examined the effect of rosehip extract on human body fat in preobese subjects.

methodsWe conducted a 12-week, single-center, double-blind, randomized, placebo-controlled study of 32 subjects who had a body mass index of ≥25 but <30. The subjects were assigned to two random groups, and they received one tablet of placebo or rosehip that contained 100 mg of rosehip extract once each day for 12 weeks with no dietary intervention. Abdominal fat area and body fat percent were measured as primary outcomes. The other outcomes were body weight and body mass index.

resultsAbdominal total fat area, abdominal visceral fat area, body weight, and body mass index decreased significantly in the rosehip group at week 12 compared with their baseline levels (P<0.01) after receiving the rosehip tablet intake, and the decreases in these parameters were significantly higher when compared with those in the placebo group. Additionally, body fat percent tended to decrease compared with the placebo group and their baseline level. Moreover, the abdominal subcutaneous fat area was significantly lower in the rosehip group than in the placebo group at week 12 after the initiation of intake (P<0.05). In addition, there were no abnormalities, subjective symptoms, and findings that may indicate clinical problems during the study period.

conclusionThese results suggest that rosehip extract may be a good candidate food material for preventing obesity.

Indexed as

dietary supplementobesityrandomized clinical trialRosa canina L.tilirosideweight loss

Identifiers

PMID25834460
PMCPMC4358417
OpenAlexW1972946253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.